Business Of Biotech Building A Biotech Hub with Intellia Therapeutics' John Leonard, M.D.
Jan 15, 2024
Dr. John Leonard, longtime CEO at Intellia Therapeutics, discusses the foundational elements of building a biotech hub, the influence of the AIDS epidemic on his career, the importance of experience and knowledge in scientific research, and Intellia's long-term DNA editing strategy. He also provides updates on the company's clinical pipeline and future plans.
AI Snips
Chapters
Transcript
Episode notes
AIDS Epidemic Influence
- John Leonard's medical training during the AIDS epidemic sparked his interest in molecular biology.
- Witnessing a disease with no known cause or cure inspired him to shift from clinical practice to research.
Technology's Role in Biotech Hubs
- New technologies like CRISPR can ignite innovation and build biotech hubs, similar to recombinant DNA's impact on Boston and the Bay Area.
- CRISPR is currently strengthening existing hubs by integrating with mature technologies.
Building Biotech Anywhere
- Building a biotech company is challenging but possible anywhere, with difficulty increasing further from established hubs.
- Key elements include insight, a driven entrepreneur with experience, funding, and access to skilled people.